Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
News 3 April 2025 Public warning: Counterfeit Ozempic pens detected in Australia The Therapeutic Goods Administration (TGA) is urging the diabetes community to remain alert following the detection of counterfeit Ozempic-labelled injection... Continue Reading
Media releases 28 March 2025 Diabetes technology access needs to be a national priority this Federal Election With the Federal Election date now set for May 3, Australia’s leading diabetes advocacy organisations are calling for election commitments... Continue Reading
News 20 March 2025 Government moves to reduce the cost of PBS medicines The Federal Government has today announced that medicines on the Pharmaceutical Benefits Scheme (PBS) will cost no more than $25... Continue Reading
